UAE
Bahrain
Jordan
Kuwait
Oman
Qatar
Saudi ArabiaHealth News
Department Of Health Publish New Guidelines For "Tobacco Harm Reduction"
Date: Jun-07-2013Struggling to quit? 'Swap tobacco for nicotine', advises new guidance from NICE Today sees the National Institute for Health and Care Excellence (NICE) publish new guidelines for tobacco harm reduction in the UK. This world first, recognises that some people may not be able to quit smoking in one step. At the heart of tobacco harm reduction is the concept that the flexible and long-term use of nicotine is always better for smokers and people around them than continuing to smoke tobacco. Experts believe this will provide a significant opportunity to help many more smokers to quit...
More Cancer Specialist Nurses To Improve Hospital Care
Date: Jun-07-2013Patients battling cancer have a better experience of care at hospitals that employ more cancer specialist nurses. Research from the University of Southampton, shows that patients of better staffed hospitals are more likely to report being given more emotional support by nurses who work well together on wards. Study author Peter Griffiths, Professor of Health Services Research at the University of Southampton, comments: "Cancer and its treatment can place a huge burden, both physical and psychological, on patients...
Matrix-Bio Options Metabolite Biomarker Technology From Purdue University To Evaluate Opportunities For New Cancer Diagnostic Tests
Date: Jun-07-2013Matrix-Bio Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive agreement with the Purdue Research Foundation optioning metabolite biomarker technology and eight patent applications to evaluate the commercial potential of cancer diagnostics tests based on the technologies...
No Proof Of Added Benefit Found For Aflibercept In Wet Age-Related Macular Degeneration
Date: Jun-07-2013Manufacturer's dossier did not contain any usable data for the comparison with ranibizumab The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment of wet age-related macular degeneration (AMD). In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the current standard therapy...
New Study Helps Explain How People Become Obsessed With Forbidden Pleasures
Date: Jun-07-2013The study, which appears in an upcoming edition of Cognitive, Affective and Behavioral Neuroscience journal, shows that when people are forbidden from something, it takes on a new level of focus. "Our findings show that when individuals are forbidden from everyday objects, our minds and brains pay more attention to them," says lead author Grace Truong, a graduate student in UBC's Dept. of Psychology. "Our brains give forbidden objects the same level of attention as our own personal possessions...
Half Of Britons Will Have Cancer During Their Lifetime By 2020
Date: Jun-07-2013According to Macmillan Cancer Support, by 2020, nearly half of the people in the UK will get cancer in their lifetime, a statistic that poses what the UK charity describes as a "herculean" challenge for the National Health Service (NHS). From an analysis of current data, the charity projects that in 2020 nearly one in two people (47%) will get cancer in his or her lifetime, but almost one in four (38%) will not die of the disease...
Never-Before-Used Targeted Treatment For Atypical Chronic Neutrophilic Leukemia
Date: Jun-07-2013A recent article in the New England Journal of Medicine describes genetic testing of a rare blood cancer called atypical chronic neutrophilic leukemia (CNL) that revealed a new mutation present in most patients with the disease. The mutation also serves as an Achilles heel, allowing doctors at the University of Colorado Cancer Center to prescribe a never-before-used, targeted treatment. The first patient treated describes his best snowboarding season ever. "I'm a crazy sports fan," says the patient. "I go 30 days a season...
Vascular Damage Blocked In Diabetes
Date: Jun-07-2013Researchers at Lund University in Sweden have discovered how to stop the destructive process that leads to cardiovascular disease in diabetic laboratory animals. It is well known that high blood sugar levels significantly raise the risk of cardiovascular disease. It is unclear, however, why this happens. An important part of the explanation may be NFAT, a protein activated when blood sugar is raised and which starts a chain of events that damage the blood vessels and accelerate the development of atherosclerosis...
Paving The Way For Protein Drugs From Bacteria
Date: Jun-07-2013A cheaper, more efficient technique for developing complex protein drugs from bacteria has been developed at the University of Sheffield. Using the bacterium E. coli, researchers from the University's Faculty of Engineering showed it was possible to vastly increase the efficiency of the cells producing specifically modified proteins, as well as improve its performance and stability. The modification is present in over two-thirds of human therapeutic drugs on the market and involves the addition of specific sugar groups to the protein backbone, a process termed glycosylation...
Health Risks May Pass To Grandchildren Of Obese Mums
Date: Jun-07-2013Health problems linked to obesity - like heart disease and diabetes - could skip an entire generation, a new study suggests. Researchers have found that the offspring of obese mothers may be spared health problems linked to obesity, while their own children then inherit them. Currently, concern about the obesity epidemic is mainly focused on the health of obese women and their children, rather than the wider family...
Stay Connected
